Alcohol intake, hypertension development and mortality in black South Africans

European Journal of Preventive Cardiology

Volumn 23, Issue 3, 2016, Pages 308-315

  Zatu, Mandlenkosi C ^a,b   Van Rooyen, Johannes M ^a   Kruger, Annamarie ^a   Schutte, Aletta E ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

cardiovascular disease; Gamma glutamyltransferase; hypertension; morbidity; percentage carbohydrate deficient transferrin; self reported alcohol intake; sub Saharan Africa

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; BIOLOGICAL MARKER; CARBOHYDRATE-DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; GAMMA-GLUTAMYLTRANSFERASE, HUMAN; TRANSFERRIN;

ADULT; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOUTH AFRICAN; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; BLACK PERSON; BLOOD; DRINKING BEHAVIOR; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SOUTH AFRICA; TIME FACTOR;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALCOHOL DRINKING; BIOMARKERS; BLOOD PRESSURE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TRANSFERRIN;

EID: 84954341899     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314563447     Document Type: Article

References (51)

1. Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223-2233.
2. Stewart S, Libhaber E, Carrington M, et al. The clinical consequences and challenges of hypertension in urban-dwelling black Africans: Insights from the Heart of Soweto Study. Int J Cardiol 2011; 146: 22-27.
3. Dalal S, Beunza JJ, Volmink J, et al. Non-communicable diseases in sub-Saharan Africa: What we know now. Int J Epidemiol 2011; 40: 885-901.
4. Poulter NR,. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: An estimate from population studies. J Hypertens 2011; 29: 1281-1282.
5. Peer N, Lombard C, Steyn K, et al. Rising alcohol consumption and a high prevalence of problem drinking in black men and women in Cape Town: The CRIBSA study. J Epidemiol Community Health 2014; 68: 446-452.
6. Opie LH, Seedat YK,. Hypertension in sub-Saharan African populations. Circulation 2005; 112: 3562-3568.
7. Ogah OS, Rayner BL,. Recent advances in hypertension in sub-Saharan Africa. Heart 2013; 99: 1390-1397.
8. Schutte AE, Schutte R, Huisman HW, et al. Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study. Int J Epidemiol 2012; 41: 1114-1123.
9. Zatu MC, Van Rooyen JM, Loots DT, et al. Self-reported alcohol intake is a better estimate of 5-year change in blood pressure than biochemical markers in low resource settings: The PURE study. J Hypertens 2014; 32: 749-755.
10. Matsumoto C, Miedema MD, Ofman P, et al. An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev 2014; 34: 159-171.
11. Kolapo KO, Vento S,. Stroke: A realistic approach to a growing problem in sub-Saharan Africa is urgently needed. Trop Med Int Health 2011; 16: 707-710.
12. Connor MD, Thorogood M, Casserly B, et al. Prevalence of stroke survivors in rural South Africa: Results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke 2004; 35: 627-632.
13. Kengne AP, Czernichow S, Stamatakis E, et al. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: Pooling of three British Health Surveys. J Hepat 2012; 57: 1083-1089.
14. Le-Ha C, Beilin LJ, Burrows S, Huang R-C, et al. Oral contraceptives use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence. Eur J Prev Cardiol 2012; 20: 947-955.
15. Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. Br Med J 2011; 342: d671-d671.
16. Curtis AB, Sherman JA, Strogatz DS, et al. Alcohol consumption and changes in blood pressure among African Americans-the Pitt County study. Am J Epidemiol 1997; 146: 727-733.
17. Briasoulis A, Agarwal V, Messerli FH,. Alcohol consumption and the risk of hypertension in men and women: A systematic review and meta-analysis. J Clin Hypertens 2012; 14: 792-798.
18. Viel G, Boscolo-Berto R, Cecchetto G, et al. Phosphatidylethanol in blood as a marker of chronic alcohol use: A systematic review and meta-analysis. Int J Mol Sci 2012; 13: 14788-14812.
19. Lioudaki E, Ganotakis ES, Mikhailidis DP,. Liver enzymes: Potential cardiovascular risk markers? Curr Pharm Des 2011; 17: 3632-3643.
20. Guangli D, Song Z, Zhang Q,. Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: A meta-analysis of prospective cohort studies. Prev Med 2013; 57: 31-37.
21. Teo K, Chow CK, Vaz M, et al. PURE Investigators writing group. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic non-communicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 58: 1-7.
22. Marfell-Jones M, Olds T, Stewart AD, et al. International standards for anthropometric assessment. Potchefstroom, South Africa: International Society for the advancement of Kinanthropometry, 2006.
23. Weber MA, Schiffrin EL, White WB, et al. Clinical Practice Guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014; 32: 3-15.
24. Haring R, Wallaschofski H, Nauck M, et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009; 50: 1403-1411.
25. Wannamethee SG, Lennon L, Shaper AG,. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008; 201: 168-175.
26. Koehler M, Sanna D, Hansen BE, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int 2014; 34: 296-304.
27. Fraser A, Harris R, Sattar N, et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: Analysis of the British Women's Heart and Health study and meta-analysis. Arterioscler Thromb Vasc Biol 2007; 27: 2729-2735.
28. Ruhl CE, Everhart JE,. Elevated serum alanine aminotransferase and gammaglutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477-485.
29. Stojakovic T, Scharnagl H, Trauner M, et al. Serum gamma-glutamyltransferase and mortality in persons undergoing coronary angiography-the Ludwigshafen Risk and Cardiovascular Health study. Atherosclerosis 2010; 208: 564-571.
30. Baros AM, Wright TM, Latham PK, et al. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment. Alcohol Alcohol 2008; 43: 192-197.
31. Liu C-F, Gu Y-T, Wang H-Y, et al. Gamma-glutamyltransferase level and risk of hypertension: A systematic review and meta-analysis. PLoS One 2012; 7: e48878-e48878.
32. Matsha TE, Macharia M, Yako YY, et al. Gamma-glutamyltransferase, insulin resistance and cardiometabolic risk profile in a middle-aged African population. Eur J Prev Cardiol 2014; 21: 1541-1548.
33. Hall P, Cash J,. What is the real function of the liver 'function' tests? Ulster Med J 2012; 81: 30-36.
34. Puukka K, Hietala J, Koivisto H, et al. Additive effects of moderate drinking and obesity on serum gamma-glutamyltransferase activity. Am J Clin Nutr 2006; 83: 1351-1354.
35. Stewart SH, Connors GJ, Hutson A,. Ethnicity and gamma-glutamyltransferase in men and women with alcohol use disorders. Alcohol Alcohol 2007; 42: 24-27.
36. Shankar A, Li J, Klein BEK, et al. Serum gamma-glutamyltransferase level and peripheral arterial disease. Atherosclerosis 2008; 199: 102-109.
37. Saijo Y, Utsugi M, Yoshioka E, et al. The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness. Nutr Metab Cardiovasc Dis 2008; 18: 211-219.
38. Mason JE, Starke RD, Van Kirk JE,. Gamma-glutamyltransferase: A novel cardiovascular risk biomarker. Prev Cardiol 2010; 13: 36-41.
39. Tsai J, Ford ES, Li C, et al. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Addict Behav 2012; 37: 78-84.
40. Peltzer K, Davids A, Njuho P,. Alcohol use and problem drinking in South Africa: Findings from a national population-based survey. Afr J Psychiatry (Johannesburg) 2011; 14: 30-37.
41. Gossage JP, Snell CL, Parry CDH, et al. Alcohol use, working conditions, job benefits, and the legacy of the 'Dop' system among farm workers in the Western Cape Province, South Africa: Hope despite high levels of risky driving. Int J Environ Res Public Health 2014; 11: 7406-7424.
42. Bortolotti F, De Paoli G, Tagliaro F,. Carbohydrate deficient transferrin (CDT) as a marker of alcohol abuse: A critical review of the literature 2001-2005. J Chromatography B 2006; 841: 96-109.
43. Solomons HD,. Carbohydrate deficient transferrin and alcoholism. Germs 2012; 12: 75-78.
44. Madhubala V, Subhashree AR, Shanthi B,. Serum carbohydrate deficient transferrin as a sensitive marker in diagnosing alcohol abuse: A case-control study. J Clin Diagn Res 2013; 7: 197-200.
45. Berkowicz A, Wallerstedt S, Wall K, et al. Carbohydrate-deficient transferrin in vitreous humour: A marker of possible withdrawal-related death in alcoholics. Alcohol Alcohol 2001; 36: 231-234.
46. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. http://www.unaids.org/sites/default/files/media-asset/20101123-globalreport-en-1.pdf (accessed 10 April 2014).
47. Fourie CM, Van Rooyen JM, Kruger A, et al. Lipid abnormalities in a never treated HIV-1 subtype C-infected African population. Lipids 2010; 45: 73-80.
48. Ikeda MLR, Barcellos NT, Alencastro PR, et al. Association of blood pressure and hypertension with alcohol consumption in HIV-infected white and non-white patients. Sci World J. Epub ahead of print 21 October 2013. DOI: 10.1155/2013/169825.
49. Braithwaite RS, Nucifora KA, Kessler J, et al. Impact of interventions targeting unhealthy alcohol use in Kenya on HIV transmission and AIDS-related deaths. Alcohol Clin Exp Res 2014; 38: 1059-1067.
50. Morojele NK, Kachieng'a MA, Mokoko E, et al. Alcohol use and sexual behaviour among risky drinkers and bar and shebeen patrons in Gauteng province. South Africa Soc Sci Med 2006; 62: 217-227.
51. Opio CK, Seremba E, Ocama P, et al. Diagnosis of alcohol misuse and alcoholic liver disease among patients in the medical emergency admission service of a large urban hospital in Sub-Saharan Africa; a cross sectional study. Pan Afr Med J 2013; 15: 23-23.